Shareholder Rights Plans: Self-Limiting Features and Redemptions; What’S up with Stapled Financing? by Joris M

Total Page:16

File Type:pdf, Size:1020Kb

Shareholder Rights Plans: Self-Limiting Features and Redemptions; What’S up with Stapled Financing? by Joris M SRLJ34#3pb.fh10 8/25/06 8:48 AM Page 1 SRLJ34#3pb.fh10 8.23.06 hg ROCHESTER SPECIALTY COMPOSITION Saint Paul, MN55164-0779 Saint Paul, DISTRIBUTION CENTER DISTRIBUTION 610 OppermanDrive Securities Regulation LawJournal P.O. Box64526 P.O. Securities Regulation Law Journal Volume 34 Number 3 Fall 2006 Is Evidence of Contacts Followed by Trading Sufficient to Infer and Prove Tipping in an Insider Trading Case? The “Plus Factor” Rule By Thomas O. Gorman Merrill Lynch v. Dabit: Federal Preemption of Holders’ Class Actions By Mark J. Loewenstein Volume 34 Number 3Volume F Shareholder Rights Plans: Self-Limiting Features and Redemptions; What’s up with Stapled Financing? By Joris M. Hogan A Comment on Restricted Stock Sold by a Non-Affiliate By Robert A. Barron **Special Update—Is it Necessary to File a Copy of Form 144 with NASDAQ? By Robert A. Barron all 2006 Quarterly Survey of SEC Rulemaking and Major Appellate Decisions By Victor M. Rosenzweig 40372241 *40372241* PERIODICALS Composite Shareholder Rights Plans: Self-Limiting Features And Redemptions; What’s Up With Stapled Financing? By Joris M. Hogan* After briefly summarizing the history and operation of shareholder rights plans, this article will discuss the vigorous attack by institutional shareholders against these plans in recent years as well as the resulting effects which include the adoption of various self-limiting features and , in some cases, outright redemption. The recent Unisuper decision by the Delaware Chancery Court may add impetus to this growing trend. Part two briefly describes stapled financing and its benefits to sellers and buy- ers in transactions where financeability may be an issue. Following a dis- cussion of certain precautions that sellers and their financial advisors of- ten take to mitigate conflict of interest concerns, the article concludes that Vice Chancellor Strine’s expressed discomfort with stapled financing in the recent Toys “R” Us decision is unlikely to turn the tide against the use of this financing technique. Shareholder Rights Plans: History And Basic Operation As takeovers increased in the 1970s, the topic of responses to hostile bids became more of a concern for corporate boards and the lawyers who advised them.1 In the face of such bids, companies had a small arsenal of defenses, including the anti-takeover statutes that had been adopted in thirty-seven states. Then, in 1982, the Supreme Court held that the Will- iams Act,2 one of the few federal statutes that address corporate decision- making, preempted any state statute that upset the balance struck by the Act.3 That decision left only the minimal protections of the Williams Act such as the requirement that unsolicited tender offers remain open for at least twenty business days.4 * Joris M. Hogan is a partner in the Corporate Group of the international law firm, Torys LLP, specializing in mergers and acquisitions, securities law and corporate governance matters. The author gratefully acknowledges the contributions of Timothy B. Martin and Carmen Korehbandi in the preparation of this article. 221 222 SECURITIES REGULATION LAW JOURNAL In the fall of 1982, Martin Lipton published his memorandum entitled, “Warrant Dividend Plan,” earning credit as the inventor of the device that restored directors’ ability to determine their company’s destiny when confronted with an unsolicited takeover bid. The warrant he proposed came to be used in many forms, but each was designed to allow the board additional time to respond to an unsolicited bid. The labels given the war- rant were just as various as its forms. While it is referred to technically as a “shareholder rights plan” or “preferred share purchase rights plan,” the colloquial name stuck after it appeared in The Wall Street Journal in the summer of 1983: the “poison pill”.5 As the use of poison pills increased, the stage was set for a confronta- tion between the corporate raiders and the proponents of these new devic- es. With state legislatures effectively sidelined by the Supreme Court’s Edgar v. MITE decision and federal judges similarly hamstrung,6 state courts were left to create a framework for takeover fights. The Delaware Supreme Court led this effort with four cases it decided in 1985: Smith v. Van Gorkom,7 Revlon, Inc. v. MacAndrews & Forbes Holdings,8 Unocal Corp. v Mesa Petroleum,9 and Moran v. Household International, Inc.10 Each case added to the framework, though Moran is regarded as a water- shed moment for the poison pill defense.11 The Delaware Supreme Court upheld the right of a board to adopt a poison pill without first getting shareholder approval and also upheld the board’s right to reject a take- over bid, subject to a new intermediate level of judicial scrutiny.12 Prior to the decision in Moran, there were thirty-five poison pills in effect; in the year after the decision, approximately 300 companies adopted a pill.13 Shareholder rights plans, though not structurally identical, generally operate in a similar fashion. After adoption of the poison pill by the board of directors, the rights are distributed to shareholders and “attach” to the company’s shares of stock. The rights are triggered automatically upon a specified event, which is typically the purchase of 10-20% of the compa- ny’s common stock without the approval of the board. After the rights are triggered, each shareholder, except for the purchaser who triggered the pill, has the right to purchase additional shares or receive other assets at a steep discount, which thereby dilutes the unwanted suitor’s shareholding to an unacceptable degree. This discriminatory discount can take the form of allowing the other shareholders to purchase more shares of the target (a “flip-in” provision) or, in the case of a merger or purchase by an- other acquiror, allowing the other shareholders to purchase a dispropor- tionate interest in the acquiror (a “flip-over” provision). In either case, the [VOL. 34:3 2006] SHAREHOLDER RIGHTS PLANS 223 massive dilution of the acquiror’s position makes it prohibitively expen- sive to complete a hostile bid for control of the target. Efforts to circumvent a poison pill by replacing the board and redeem- ing the pill can be stifled by additional provisions that prevent or delay a board from redeeming the plan. These can take the form of a provision within the plan itself, such as a dead-hand,14 no-hand15 or slow hand16 provision, or by staggering the board so that more than one annual elec- tion cycle must be completed before an acquiror-friendly board can be constituted to redeem the pill. The pill therefore affords a board of direc- tors some control over the takeover process through its ability to redeem the rights for a period before or within a specified period after they are triggered, and through the board’s power to grant an exemption from the pill to friendly buyers. This additional control usually gives the board of directors of the target company sufficient time to examine alternatives to an unsolicited bid. Institutional Shareholders’ Frontal Attack On Poison Pills Nearly twenty-five years after its invention, the poison pill continues to evolve. Because of the power it gives to the board and the perceived danger of entrenchment when shareholder interests might be best served by ac- cepting an unsolicited bid, companies have begun to insert self-limiting features into their shareholder rights plans. This movement to limit a board’s ability to “just say no” has been led by the large institutional share- holders and the corporate governance services they constitute.17 Service providers such as Institutional Shareholder Services (ISS), the Council of Institutional Investors, and the Investor Responsibility Research Center (IRRC)18 have each implemented policies to direct members on how to re- spond to boards that propose new or amended poison pills.19 ISS’ policy on shareholder rights plans is to evaluate management pro- posals on a case-by-case basis. However, ISS does have general guidelines regarding poison pills and recommends that such plans should have a “trig- ger” that is not lower than 20%, have a term not to exceed three years, con- tain no provisions that limit a future board’s ability to redeem the pill (such as a dead-hand provision), and have a “qualifying offer” exception (i.e., be a “chewable pill” that will fall away under certain circumstances). In recent years, institutional investors have been winning the battle against poison pills and their unilateral adoption by boards of directors.20 At the end of 2005, for example, 46% of the S&P 500 companies had a poison pill, a nearly eight-point drop from the number of companies that 224 SECURITIES REGULATION LAW JOURNAL had one at the end of 2004.21 The number of companies with poison pills has been on the decline since 2002, when 60% of the S&P 500 had poi- son pill defenses. Trends In Self-Limiting Features After a shareholder proposal regarding a poison pill is approved by a majority of the shareholders, a board of directors typically will choose to take no action, modify or redeem its poison pill, or, in some cases, make commitments regarding the future adoption of a poison pill. For those that choose to modify their poison pills, there are many options available. The board may, for example, attempt to accommodate the shareholders by: • putting the shareholder rights plan or future plans up for a binding shareholder vote; • adopting “chewable pill” provisions that carve out certain types of qualifying acquisition proposals or acquisition proposals that are approved by shareholders; • including a “permitted offer” exception; • including a three-year independent director evaluation (TIDE) provision; • shortening the term of the shareholder rights plan (a “sunset provi- sion”); or • increasing the shareholder rights plan’s trigger threshold (usually to 15 or 20%); or • provide for more than one trigger level before the rights flip-in or flip-out.22 Frequently, however, institutional investors, who are the main propo- nents of shareholder proposals that oppose or seek to limit poison pills, are not satisfied with these “shareholder-friendly” self-limiting features.
Recommended publications
  • Canadian Public Company Mergers & Acquisitions Guide
    Canadian Public Company Mergers & Acquisitions A practical guide to the issues surrounding acquisitions of public companies in Canada. CANADIAN PUBLIC COMPANY MERGERS & ACQUISITIONS Osler, Hoskin & Harcourt llp Table of Contents Acquisition Structures 3 Pre-Acquisition Considerations 16 Minority Shareholder Protections 21 Directors’ Duties 23 Competition Law and Foreign Investment Review 28 2 CANADIAN PUBLIC COMPANY MERGERS & ACQUISITIONS Osler, Hoskin & Harcourt llp 1 Acquisition Structures While several different methods exist to acquire control of a Canadian public company, M&A transactions in Canada are most commonly effected by a “plan of arrangement” and less frequently by a “take-over bid.” These transaction structures are outlined below. PLAN OF ARRANGEMENT Overview A statutory arrangement, commonly referred to as a “plan of arrangement,” is a voting transaction governed by the corporate laws of the target company’s jurisdiction of incorporation. It is first negotiated with the target company’s board of directors and remains subject to the approval of the target company’s shareholders at a special meeting held to vote on the proposed transaction. Notably, an arrangement also requires court approval. Due to the ability to effect the acquisition of all of the outstanding securities of a target in a single step and its substantial structuring flexibility, the majority of board-supported transactions are structured as arrangements. Due to the ability to effect the acquisition of Court Supervision and Approval all of the outstanding Unlike any other transaction structure typically used to effect a change of corporate control, an arrangement is a court-supervised process. securities of a target in The target company applies to court to begin the process of effecting the a single step and its arrangement.
    [Show full text]
  • Proxy Voting Guidelines Benchmark Policy Recommendations TITLE
    UNITED STATES Proxy Voting Guidelines Benchmark Policy Recommendations TITLE Effective for Meetings on or after February 1, 2021 Published November 19, 2020 ISS GOVERNANCE .COM © 2020 | Institutional Shareholder Services and/or its affiliates UNITED STATES PROXY VOTING GUIDELINES TABLE OF CONTENTS Coverage ................................................................................................................................................................ 7 1. Board of Directors ......................................................................................................................................... 8 Voting on Director Nominees in Uncontested Elections ........................................................................................... 8 Independence ....................................................................................................................................................... 8 ISS Classification of Directors – U.S. ................................................................................................................. 9 Composition ........................................................................................................................................................ 11 Responsiveness ................................................................................................................................................... 12 Accountability ....................................................................................................................................................
    [Show full text]
  • Adopting a Poison Pill in Response to Shareholder Activism
    IN THE BOARDROOM CAPITAL MARKETS & CORPORATE GOVERNANCE Ismagilov/Shutterstock.com Adopting a Poison Pill in Response to Shareholder Activism In his regular column, Frank Aquila drafts a memo to a board explaining the considerations it should evaluate when deciding whether to adopt a poison pill. FRANCIS J. AQUILA PARTNER SULLIVAN & CROMWELL LLP Frank has a broad multidisciplinary practice that includes extensive experience in negotiated and unsolicited mergers and acquisitions, activist and takeover defense, complex cross-border transactions, global joint ventures, and private equity transactions. He regularly counsels boards of directors and board committees on corporate governance matters and crisis management. MEMORANDUM TO: The Board of Directors FROM: Frank Aquila RE: Considerations When Adopting a Poison Pill in Response to Shareholder Activism As we have discussed, the Investor has just filed a Schedule 13D with the Securities and Exchange Commission disclosing equity holdings in the Company equal to 8.8% of the Company’s common stock. The Investor has also disclosed its intentions to increase its stake to approximately 15%, seek representation on the Company’s Board, and then advocate for either a spin-off of certain business units or a sale of the Company. 22 April 2016 | Practical Law © 2016 Thomson Reuters. All rights reserved. To strengthen the Board’s negotiating leverage and provide adequate time to evaluate what alternatives would be in the best interests of the Company and its shareholders, the Board is considering adopting a shareholder rights plan, commonly known as a poison pill, with a 10% threshold. Correctly implemented, the triggering of this poison pill would massively dilute the Investor’s voting and equity stake as soon as the Investor acquires 10% of the Company’s outstanding common stock by allowing all other shareholders to purchase additional shares at a steep discount.
    [Show full text]
  • 1 IRREVOCABLE SUBSCRIPTION UNDERTAKING TO: Tryg A/S
    EXECUTION VERSION IRREVOCABLE SUBSCRIPTION UNDERTAKING TO: Tryg A/S Klausdalsbrovej 601 2670 Ballerup Denmark ("Tryg") and Morgan Stanley & Co. International plc 25 Cabot Square Canary Wharf London E14 4QA United Kingdom ("Morgan Stanley") and Danske Bank A/S Holmens Kanal 2 - 12 DK-1092 Copenhagen Denmark ("Danske Bank" and together with Morgan Stanley, the "Underwriters") FROM: TryghedsGruppen SMBA Hummeltoftevej 49 2830 Virum Denmark (the "Foundation", "us", "we") Date: 18 November 2020 1 RECOMMENDED CASH OFFER TO ACQUIRE RSA INSURANCE GROUP PLC AND RIGHTS ISSUE IN TRYG A/S 1.1 We understand that Tryg together with Regent Bidco Limited (“Bidco”) and Intact Financial Corporation ("Intact") contemplate an acquisition by Bidco of the entire issued and to be issued share capital of RSA Insurance Group plc ("RSA") (the "Acquisition") by way of court-sanctioned scheme of arrangement under Part 26 of the UK Companies Act 2006 (including any new, increased, renewed or revised scheme of arrangement) (the ''Scheme''). In connection with the Acquisition, 1 Intact and Tryg have entered into a Separation Agreement with respect to the Scandinavia Sepa- ration, on the terms and conditions as summarised in the draft announcement attached to this irrevocable undertaking as Appendix 1.1 (the ''Rule 2.7 Announcement''), together with such additional terms and conditions as may be required by the Applicable Requirements (as defined in Clause 1.3 below) or as may be agreed in writing between Tryg, Intact, Bidco and RSA provided that such additional terms shall not increase Foundation's payment obligations under this irrevoca- ble undertaking or change the consideration contributed by Tryg to the Acquisition as indicated in the Rule 2.7 Announcement without the Foundation's prior consent.
    [Show full text]
  • The SEC and the Failure of Federal, Takeover Regulation
    Florida State University Law Review Volume 34 Issue 2 Article 2 2007 The SEC and the Failure of Federal, Takeover Regulation Steven M. Davidoff [email protected] Follow this and additional works at: https://ir.law.fsu.edu/lr Part of the Law Commons Recommended Citation Steven M. Davidoff, The SEC and the Failure of Federal, Takeover Regulation, 34 Fla. St. U. L. Rev. (2007) . https://ir.law.fsu.edu/lr/vol34/iss2/2 This Article is brought to you for free and open access by Scholarship Repository. It has been accepted for inclusion in Florida State University Law Review by an authorized editor of Scholarship Repository. For more information, please contact [email protected]. FLORIDA STATE UNIVERSITY LAW REVIEW THE SEC AND THE FAILURE OF FEDERAL TAKEOVER REGULATION Steven M. Davidoff VOLUME 34 WINTER 2007 NUMBER 2 Recommended citation: Steven M. Davidoff, The SEC and the Failure of Federal Takeover Regulation, 34 FLA. ST. U. L. REV. 211 (2007). THE SEC AND THE FAILURE OF FEDERAL TAKEOVER REGULATION STEVEN M. DAVIDOFF* I. INTRODUCTION.................................................................................................. 211 II. THE GOLDEN AGE OF FEDERAL TAKEOVER REGULATION.................................. 215 A. The Williams Act (the 1960s) ..................................................................... 215 B. Going-Privates (the 1970s)......................................................................... 219 C. Hostile Takeovers (the 1980s)..................................................................... 224 1. SEC Legislative
    [Show full text]
  • KS Bancorp Shareholder Rights Plan Frequently Asked Questions
    FREQUENTLY ASKED QUESTIONS (“FAQ”) CONCERNING THE ADOPTION OF THE SHAREHOLDER RIGHTS PLAN ON FEBRUARY 9, 2018 1. What is a shareholder rights plan? A shareholder rights plan is a commonly used anti- takeover device utilized to protect a corporation and its shareholders against unwelcome takeovers. Such plans often provide for the issuance of additional shares to the corporation’s shareholders in order to dilute the ownership of a hostile third party. 2. Why has KS Bancorp adopted a shareholder rights plan? Last year, we received informal, non-binding “indications of interest” from First Citizens BancShares (“First Citizens”). Your Board engaged a nationally-recognized investment banking firm to conduct a detailed analysis of the indications of interest and other strategic alternatives. After thorough and extended consideration of the analysis and other relevant information, your Board unanimously determined to reject the indications of interest and resolved that the continued independent operation of KS Bancorp is in the best interest of our shareholders. We feel our recently announced yearend results support this decision. Previously, the indications of interest created significant unrest among our employees and our existing and prospective clients. Notwithstanding our rejection of First Citizens’ indications of interest, we have recently learned that First Citizens’ bank subsidiary (and our direct competitor), First-Citizens Bank & Trust Company, has directly approached certain of our customers and shareholders, expressing its intent
    [Show full text]
  • Investor Bulletin: Reverse Mergers
    e Investor Bulletin: Reverse Mergers Introduction merger surviving public company are primarily, if not solely, those of the former private operating company. Many private companies, including some whose operations are located in foreign countries, seek to ac- cess the U.S. capital markets by merging with existing Why Pursue a Reverse Merger? public companies. These transactions are commonly referred to as “reverse mergers” or “reverse takeovers A private operating company may pursue a reverse (RTOs).” merger in order to facilitate its access to the capi- tal markets, including the liquidity that comes with having its stock quoted on a market or listed on an What is a Reverse Merger? exchange. Private operating companies generally have access only to private forms of equity, while public In a reverse merger transaction, an existing public companies potentially have access to funding from a “shell company,” which is a public reporting company broader pool of public investors. A reverse merger with few or no operations,1 acquires a private oper- often is perceived to be a quicker and cheaper method ating company—usually one that is seeking access of “going public” than an initial public offering (IPO). to funding in the U.S. capital markets. Typically, the The legal and accounting fees associated with a reverse shareholders of the private operating company ex- merger tend to be lower than for an IPO. And while change their shares for a large majority of the shares the public shell company is required to report the of the public company. Although the public shell reverse merger in a Form 8-K filing with the SEC, company survives the merger, the private operating there are no registration requirements under the company’s shareholders gain a controlling interest in Securities Act of 1933 as there would be for an IPO.
    [Show full text]
  • A Theory of Merger-Driven Ipos
    JOURNAL OF FINANCIAL AND QUANTITATIVE ANALYSIS Vol. 46, No. 5, Oct. 2011, pp. 1367–1405 COPYRIGHT 2011, MICHAEL G. FOSTER SCHOOL OF BUSINESS, UNIVERSITY OF WASHINGTON, SEATTLE, WA 98195 doi:10.1017/S0022109011000421 A Theory of Merger-Driven IPOs Jim Hsieh, Evgeny Lyandres, and Alexei Zhdanov∗ Abstract We propose a model that links a firm’s decision to go public with its subsequent takeover strategy. A private bidder does not know a firm’s true valuation, which affects its gain from a potential takeover. Consequently, a private bidder pursues a suboptimal restructur- ing policy. An alternative route is to complete an initial public offering (IPO) first. An IPO reduces valuation uncertainty, leading to a more efficient acquisition strategy, therefore enhancing firm value. We calibrate the model using data on IPOs and mergers and acqui- sitions (M&As). The resulting comparative statics generate several novel qualitative and quantitative predictions, which complement the predictions of other theories linking IPOs and M&As. For example, the time it takes a newly public firm to attempt an acquisition of another firm is expected to increase in the degree of valuation uncertainty prior to the firm’s IPO and in the cost of going public, and it is expected to decrease in the valuation surprise realized at the time of the IPO. We find strong empirical support for the model’s predictions. I. Introduction Recent empirical studies suggest that firms’ initial public offerings (IPOs) and mergers and acquisitions (M&As) are not unrelated. According to a survey of ∗Hsieh, [email protected], School of Management, George Mason University, 4400 University Dr., Fairfax, VA 22030; Lyandres, [email protected], School of Management, Boston University, 595 Commonwealth Ave., Boston, MA 02445; and Zhdanov, [email protected], University of Lausanne, Extranef 237, Lausanne 1007, Switzerland and Swiss Finance Institute.
    [Show full text]
  • Frequently Asked Questions About Initial Public Offerings
    FREQUENTLY ASKED QUESTIONS ABOUT INITIAL PUBLIC OFFERINGS Initial public offerings (“IPOs”) are complex, time-consuming and implicate many different areas of the law and market practices. The following FAQs address important issues but are not likely to answer all of your questions. • Public companies have greater visibility. The media understanding IPOS has greater economic incentive to cover a public company than a private company because of the number of investors seeking information about their What is an IPO? investment. An “IPO” is the initial public offering by a company • Going public allows a company’s employees to of its securities, most often its common stock. In the share in its growth and success through stock united States, these offerings are generally registered options and other equity-based compensation under the Securities Act of 1933, as amended (the structures that benefit from a more liquid stock with “Securities Act”), and the shares are often but not an independently determined fair market value. A always listed on a national securities exchange such public company may also use its equity to attract as the new York Stock exchange (the “nYSe”), the and retain management and key personnel. nYSe American LLC or one of the nasdaq markets (“nasdaq” and, collectively, the “exchanges”). The What are disadvantages of going public? process of “going public” is complex and expensive. • The IPO process is expensive. The legal, accounting upon the completion of an IPO, a company becomes and printing costs are significant and these costs a “public company,” subject to all of the regulations will have to be paid regardless of whether an IPO is applicable to public companies, including those of successful.
    [Show full text]
  • Amended and Restated Shareholder Rights Plan Agreement
    AMENDED AND RESTATED SHAREHOLDER RIGHTS PLAN AGREEMENT DATED AS OF APRIL 26, 2013MAY 3, 2019 BETWEEN TRANSCANADA CORPORATION AND COMPUTERSHARE TRUST COMPANY OF CANADA AS RIGHTS AGENT - i - AMENDED AND RESTATED SHAREHOLDER RIGHTS PLAN AGREEMENT TABLE OF CONTENTS Article 1 - INTERPRETATION......................................................................................................2 1.1 Certain Definitions ..........................................................................................................2 1.2 Currency ........................................................................................................................15 1.3 Headings ........................................................................................................................15 1.4 Calculation of Number and Percentage of Beneficial Ownership of Outstanding Voting Shares ................................................................................................................15 1.5 Acting Jointly or in Concert ......................................................................................1516 1.6 Generally Accepted Accounting Principles...................................................................16 Article 2 - THE RIGHTS ..............................................................................................................16 2.1 Issue of Rights: Legend on Common Share Certificates..............................................16 2.2 Initial Exercise Price; Exercise of Rights; Detachment of Rights.................................17
    [Show full text]
  • Doing Public M&A Deals in Pennsylvania
    Doing Public M&A Deals in Pennsylvania:Copyright 2004 Dechert LLP. All rights reserved. Materials Minesweeper have been abridged from laws, court decisions, and Required administrative rulings and should not be considered as legal opinions on specific facts or as a substitute for legal counsel. by William G. Lawlor, Peter D. Cripps, and Ian A. Hartman Dechert LLP The Review of Securities and Commodities Regulation Vol. 38, No. 15 September 7, 2005 This article first appeared in The Review of Securities & Commodities Regulation, and is published here with the permission of Standard & Poor’s. www.dechert.com d Doing Public M&A Deals in Pennsylvania: Minesweeper Required By William G. Lawlor, Peter D. Cripps, and Ian A. Hartman Anti-takeover Statutes in Pennsylvania, among Other Provisions, Give Target Shareholders a Put, Impose a Moratorium on Mergers with Interested Shareholders, and Prohibit Voting of Control Shares. In Addition, in Change-of-control Situations, the Target’s Board May Consider the Interests of Corporate Stakeholders Other than Stockholders, and Its Decisions Will Not be Subject to Enhanced Scrutiny under the Business Judgment Rule. As a response to the 1980s wave of hostile takeovers, many state legislatures adopted or strengthened anti-takeover statutes. Today, virtually all states have such laws, but only a few, including Massachusetts, Ohio, Virginia and Wisconsin , rival Pennsylvania in terms of breadth and complexity (and to some cynics, opacity) of their statutes. The Pennsylvania anti-takeover statutes enacted in 1990 were considered so draconian that they ignited a nationwide firestorm of shareholder protest. CalPERS chief executive Dale Hanson summed it up for many investors when he wrote at the time of passage: “Although the Pennsylvania antitakeover legislation has been characterized as ‘protective’ of corporations, we believe the bill will actually have an ‘anti-business’ effect by discouraging investors from entrusting their assets in Pennsylvania companies.”1 Many public Pennsylvania companies took note of the shareholder protests.
    [Show full text]
  • Accounting Quality, Corporate Acquisition, and Financing Decisions*
    Accounting Quality, Corporate Acquisition, and Financing Decisions* Sangwan Kim Kenan-Flagler Business School University of North Carolina at Chapel Hill 300 Kenan Center Drive, Campus Box 3490, McColl Building Chapel Hill, NC 27599 [email protected] January 2013 Abstract This paper examines the extent to which the quality of financial accounting information disciplines manager interests to align with stockholder interests in corporate acquisition and financing decisions. I find that, after controlling for financing constraints, recent performance, and payout policy, the tendency of firm managers to time the market is significantly constrained for firms with high-quality financial accounting information. Further, I find that the disciplining impact of accounting information is mostly driven by firms that bid for acquisitions financed with stock issuance. I also provide corroborating evidence by examining a similar disciplining role of financial accounting information in the seasoned public offering markets. I find no such effect for potential acquisitions financed through cash. The evidence suggests that high-quality accounting information allows stockholders to discipline firm managers that are motivated to take advantage of the misevaluation. Further, the results suggest the effectiveness of accounting information as a control mechanism is pronounced for firms that pursue more value-decreasing investment projects. JEL Classification: G02, G32, G34, M41 Keywords: Accounting quality, corporate governance, market timing, mergers and
    [Show full text]